Wealth Enhancement Advisory Services, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $44.5 Billion
- Q3 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 14,498 shares of ARWR stock, worth $283,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,498
Previous 8,074
79.56%
Holding current value
$283,145
Previous $209,000
33.97%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.8MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$306 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$239 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$174 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$124 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$95.4 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.07B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...